Related references
Note: Only part of the references are listed.A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain
Richard L. Rauck et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Intrathecal ziconotide in the treatment of chronic nonmalignant pain: A randomized, double-blind, placebo-controlled clinical trial
MS Wallace et al.
NEUROMODULATION (2006)
Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS - A randomized controlled trial
PS Staats et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain
GP Miljanich
CURRENT MEDICINAL CHEMISTRY (2004)
Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections
KA Follett et al.
ANESTHESIOLOGY (2004)
The combined effects of N-type calcium channel blockers and morphine on A delta versus C fiber mediated nociception
V Pirec et al.
ANESTHESIA AND ANALGESIA (2001)
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
LM Bohn et al.
NATURE (2000)
Current practices in intraspinal therapy - A survey of clinical trends and decision making
SJ Hassenbusch et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats
YX Wang et al.
PAIN (2000)
Share Paper
